companydata.dkcompanydata.dk

ZEMA Pharma Consulting ApS: Financial statements 2025

CVR: 42680427

Source: annual report 2025, Danish Business Authority

01/10/2024 – 30/09/2025

ZEMA Pharma Consulting ApS (CVR 42680427) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 102,227 and a net result of DKK -216,744 compared with DKK -281,625 the year before. That is a decrease of 21.8% compared with the year before. Equity in the 2025 report amounted to DKK 354,543. The solvency ratio was 44.9%. The company had 1 employee in the financial year.

Gross Profit
DKK 102,227
Profit/Loss
DKK -216,744
Equity
DKK 354,543
Total Assets
DKK 788,913
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-102K-217K355K1
2024-131K-282K571K1
2023-1.5M812K853K1
2022-1.1M790K830K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ZEMA Pharma Consulting ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About ZEMA Pharma Consulting ApS

ZEMA Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Torkild Hansen. The company is owned by Mads Torkild Hansen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 102,227 and a net result of DKK -216,744 compared with DKK -281,625 the year before. Equity in the 2025 report amounted to DKK 354,543.

Source: annual report 2025, Danish Business Authority

Other financial years